Due to the non-specificity, recent studies have been carried out to optimize the application of CRP in IBD, such as CRP/ALB, which is a newly-identified optimizing index integrating CRP and albumin and has been reported to be related to the disease activity in CD and UC (10, 11, 19, 20, 27–29). Here, CRP is linked to inflammatory bowel disease.